Krystal Biotech Inc (KRYS)
156.91
+1.23
(+0.79%)
USD |
NASDAQ |
Apr 26, 13:31
Krystal Biotech Net Income (TTM): 10.93M for Dec. 31, 2023
Net Income (TTM) Chart
Historical Net Income (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | 10.93M |
| September 30, 2023 | -29.81M |
| June 30, 2023 | -140.41M |
| March 31, 2023 | -135.31M |
| December 31, 2022 | -139.98M |
| September 30, 2022 | -129.73M |
| June 30, 2022 | -115.47M |
| March 31, 2022 | -103.72M |
| December 31, 2021 | -69.57M |
| September 30, 2021 | -58.15M |
| June 30, 2021 | -52.17M |
| March 31, 2021 | -42.64M |
| December 31, 2020 | -32.17M |
| September 30, 2020 | -27.14M |
| Date | Value |
|---|---|
| June 30, 2020 | -21.80M |
| March 31, 2020 | -20.32M |
| December 31, 2019 | -19.09M |
| September 30, 2019 | -17.44M |
| June 30, 2019 | -15.92M |
| March 31, 2019 | -12.85M |
| December 31, 2018 | -10.89M |
| September 30, 2018 | -8.574M |
| June 30, 2018 | -11.09M |
| March 31, 2018 | -9.575M |
| December 31, 2017 | -7.919M |
| September 30, 2017 | -7.153M |
| June 30, 2017 | -2.202M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (TTM) Range, Past 5 Years
-140.41M
Minimum
Jun 2023
10.93M
Maximum
Dec 2023
-61.05M
Average
-42.64M
Median
Mar 2021
Net Income (TTM) Benchmarks
| Axsome Therapeutics Inc | -239.24M |
| Alnylam Pharmaceuticals Inc | -440.24M |
| Catalyst Pharmaceuticals Inc | 71.41M |
| Ionis Pharmaceuticals Inc | -366.29M |
| Madrigal Pharmaceuticals Inc | -373.63M |